The Federal Medical and Biological Agency (FMBA) of Russia has announced the development of a drug to fight Covid-19. Pre-clinical trials have demonstrated its 99% effectiveness, announces the institution.
The Federal Biomedical Agency has developed and patented a unique drug of its kind against Covid-19, agency official Veronika Skvortsova announced on December 30 during a meeting with Russian Prime Minister Mikhail Michoustine.
“The drug I would like to talk about is the first etiotropic drug that directly affects the virus. It is an antidote for the coronavirus, ”she said noting that pre-clinical studies have been completed and have shown the drug to be“ completely safe ”and“ very effective ”. [Le terme «étiotrope» signifie que le traitement est dirigé contre la cause d’une maladie, ndlr.]
Veronika Skvortsova informed the Prime Minister that the FMBA was ready to submit the request for authorization to enter the clinical trials stage and that it hoped to obtain it before the end of the year. “If clinical trials confirm the effectiveness of this drug, it will be the first effective and safe direct-acting antiviral drug that has no equivalent in the world,” she explained.
In May, the Russian Health Ministry approved a coronavirus drug called Avifavir, a treatment based on Favipiravir, a drug developed in Japan where it is widely used as the basis for antiviral treatments.
Later in August, Russia became the first country to announce the registration of its Covid-19 vaccine called Sputnik V. After a series of tests, it was found to be 95% effective. In early December, Russian President Vladimir Putin ordered the launch of the mass vaccination campaign, which finally began in Moscow on December 5.